title: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
abstract: Infection causes disturbances in lipid metabolism that may be mediated by cytokines. Therefore we studied plasma lipids, lipoproteins, triglyceride (TG) metabolism, and serum cytokines in three groups: patients with the acquired immunodeficiency syndrome (AIDS) without active secondary infection, patients with evidence of human immunodeficiency virus infection but without clinical AIDS (HIV+), and controls. Plasma TGs and FFA were increased in AIDS, while plasma cholesterol, high density lipoprotein (HDL) cholesterol, apolipoprotein-A-1 (Apo-A-1), low density lipoprotein (LDL) cholesterol, and Apo-B-100 levels were decreased. Increased TG levels in AIDS were primarily due to increases in very low density lipoprotein of normal composition; in addition, LDL and HDL were TG enriched. In HIV+, TGs and FFA were not increased, but total cholesterol, HDL cholesterol, Apo-A-1, and Apo-B-100 were significantly decreased. Interferon-alpha (IFN alpha) and C-reactive protein levels were increased in AIDS, but tumor necrosis factor and haptoglobin levels were not. There was a significant correlation between plasma TGs and IFN alpha levels (r = 0.477; P less than 0.01), but not between TGs and tumor necrosis factor, C-reactive protein, haptoglobin, or P-24 antigen. In addition, there was no relationship between circulating IFN alpha levels and plasma cholesterol, HDL cholesterol, Apo-A-1, LDL cholesterol, Apo-B-100, or FFA. TG clearance time and postheparin lipase were significantly decreased in AIDS and HIV+. There was a strong correlation between serum IFN alpha levels and TG clearance time in AIDS and HIV+ (r = 0.783; P less than 0.001). In summary, decreases in cholesterol and cholesterol containing lipoproteins (including HDL) in both AIDS and HIV+ precede the appearance of hypertriglyceridemia and are not related to IFN alpha or TG levels. Our data raise the possibility that with development of AIDS, subsequent increases in IFN alpha may contribute to increases in plasma TG levels in part by decreasing the clearance of TG.
authors.affiliation: Department of Medicine, University of California, San Francisco.
authors.forename: C
authors.initials: C
authors.lastname: Grunfeld
authors.forename: M
authors.initials: M
authors.lastname: Pang
authors.forename: W
authors.initials: W
authors.lastname: Doerrler
authors.forename: J K
authors.initials: JK
authors.lastname: Shigenaga
authors.forename: P
authors.initials: P
authors.lastname: Jensen
authors.forename: K R
authors.initials: KR
authors.lastname: Feingold
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism*; D000209:Acute-Phase Proteins / Q000032:analysis; D016655:HIV Core Protein p24 / Q000097:blood; D015658:HIV Infections / Q000378:metabolism*; D006801:Humans; D016898:Interferon-alpha / Q000097:blood*; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D014280:Triglycerides / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
chemical_list: D000209:Acute-Phase Proteins; D016655:HIV Core Protein p24; D016898:Interferon-alpha; D008074:Lipoproteins; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha